CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 139 enrolled
Drug / intervention
Isovue 370 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02170688
NCT02170688Phase 4Completed

Use of Electrical Impedence to Measure Lean Body Weight as a Determinant of the Dose of Contrast Media for Abdominal CT

Duke University·interventional·Posted Jun 23, 2014·Updated Jan 7, 2015

In Brief

A Phase 4 clinical trial evaluating Isovue 370 and Weight calculation for IV Contrast Dosing. Completed, enrolled 139 participants.

Detailed Summary

There are several different methods that can be used to determine the dose of iodinated contrast material for a CT scan. These include a standard fixed dose, a dose based on total body weight, a dose based on body mass index, a dose based on lean body weight, and a dose based on estimated lean body weight. The fixed dose method uses a predetermined amount of contrast material for all patients having a CT scan of the abdomen regardless of size. This is the standard procedure currently used at Duke. The other methods use the patient's weight, either the total body weight or lean body weight, to determine the amount of contrast necessary for the CT exam. For this study, the investigators will use the fixed dose, total body weight, the lean body weight, and estimated lean body weight methods. The purpose of this study is to evaluate these five methods of determining the IV contrast volume and which may be best for abdominal CT scanning.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--

Timeline

Phase 4CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 23, 2014
Enrollment StartFeb 1, 2004
Primary CompletionJul 1, 2014
TodayJul 2, 2026
Enrollment to primary: 10.4 yearsPosted 12.0 years ago

Interventions

Isovue 370drug

All contrast media doses administered for this study are within the FDA approved dose range in the package insert.

Weight calculationother